Gebraad, A.; Ohlsbom, R.; Miettinen, J.J.; Emeh, P.; Pakarinen, T.-K.; Manninen, M.; Eskelinen, A.; Kuismanen, K.; Slipicevic, A.; Lehmann, F.;
et al. Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen. Cells 2022, 11, 1574.
https://doi.org/10.3390/cells11091574
AMA Style
Gebraad A, Ohlsbom R, Miettinen JJ, Emeh P, Pakarinen T-K, Manninen M, Eskelinen A, Kuismanen K, Slipicevic A, Lehmann F,
et al. Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen. Cells. 2022; 11(9):1574.
https://doi.org/10.3390/cells11091574
Chicago/Turabian Style
Gebraad, Arjen, Roope Ohlsbom, Juho J. Miettinen, Promise Emeh, Toni-Karri Pakarinen, Mikko Manninen, Antti Eskelinen, Kirsi Kuismanen, Ana Slipicevic, Fredrik Lehmann,
and et al. 2022. "Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen" Cells 11, no. 9: 1574.
https://doi.org/10.3390/cells11091574
APA Style
Gebraad, A., Ohlsbom, R., Miettinen, J. J., Emeh, P., Pakarinen, T. -K., Manninen, M., Eskelinen, A., Kuismanen, K., Slipicevic, A., Lehmann, F., Nupponen, N. N., Heckman, C. A., & Miettinen, S.
(2022). Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen. Cells, 11(9), 1574.
https://doi.org/10.3390/cells11091574